CN Patent
CN119638675A — 一种嘧啶苯胺类化合物的晶型、制备方法及应用
Assigned to Zhengzhou Tongyuankang Pharmaceutical Co ltd · Expires 2025-03-18 · 1y expired
What this patent protects
本发明涉及一种嘧啶苯胺类化合物的酸式盐的多晶型、制备方法及应用。具体地,本发明公开了如式(A)化合物的酸式盐的多晶型和其制备方法,以及所述的多晶型的应用。综合热力学稳定性关系和固态性质评估的结果,本发明提供如式(A)的枸橼酸盐晶型Ⅰ为优选晶型,理化性质稳定,可更好地用于临床。
USPTO Abstract
本发明涉及一种嘧啶苯胺类化合物的酸式盐的多晶型、制备方法及应用。具体地,本发明公开了如式(A)化合物的酸式盐的多晶型和其制备方法,以及所述的多晶型的应用。综合热力学稳定性关系和固态性质评估的结果,本发明提供如式(A)的枸橼酸盐晶型Ⅰ为优选晶型,理化性质稳定,可更好地用于临床。
Drugs covered by this patent
- Inlyta (Axitinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.